Healthcare Industry News

By order of a U.S. bankruptcy court, Tiger Group and Liquidity Services on Aug. 10 will auction OncoSec Medical Inc.'s former immunotherapy laboratory and R&D facility in San Diego.

In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved the first at-home oral pill, zuranolone, which will be sold under the brand named Zurzuvae, for treating perinatal or postpartum depression (PPD) – a condition one in eight birthing women experience.

JIYA Facial Cosmetic Surgery is delighted to offer their patients the latest innovation in laser treatments to produce a more youthful and healthy appearance with noticeable results in just one session.

Ceek Women's Health, an award-winning medical device company, is proud to introduce the Nella Single-Use Vaginal Speculum with Integrated Sidewall Retractors and LED Light.

A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a diagnosis can be made with cystoscopy, the most common method of detection, according to a new study*.

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.

Picarro, Inc. and LESNI A/S announced a strategic partnership aimed at delivering industry-leading Ethylene Oxide (EtO or EO) monitoring solutions to medical device and contract sterilization facilities around the world.

Waters Corporation (NYSE:WAT) introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use.

DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented a pooled analysis from two clinical studies evaluating the performance of the company's device in detecting skin cancer.

Intera Oncology® Inc. has reintroduced Hepatic Artery Infusion (HAI) therapy to the market after its discontinuation in 2018 by the prior manufacturer dismayed patients and physicians. Hepatic Artery Infusion therapy is giving people with colorectal cancer that has spread to the liver and those with bile duct cancer confined to the liver new hope by delivering local chemotherapy directly to tumors while minimizing side effects elsewhere in the body.